A trial is not a freemium plan. The clock is the whole point. The trial exists to compress the evaluation into a defined window and force a buying decision at the end of it.
A free trial is a go-to-market mechanic that gives a prospect full access to a paid product for a fixed window, usually seven, fourteen, thirty, or sixty days. When the window closes the user either converts to a paying customer or loses access. Trials fit high-consideration software where the value is visible fast, and the industry benchmark for trial-to-paid conversion sits between fifteen and twenty-five percent.
The six things to know before launching a free trial, and the one benchmark that tells you whether the trial is doing its job.
A free trial grants complete or near-complete access to a paid product for a bounded period, usually seven to sixty days. At expiration the trial converts to a paid plan or the account is downgraded, paused, or deactivated. The clock is deliberate and the whole mechanic hinges on it.
Freemium gives a limited product forever with no card. A trial gives the full product briefly, often behind a card. Trials optimize for a fast decision inside a known window. Freemium optimizes for long-tail acquisition and slow, voluntary upgrade. The two are different tools for different buying motions.
Healthy B2B SaaS trial-to-paid conversion lands between fifteen and twenty-five percent of trial starts. Below ten percent usually means a leaky activation flow or a mismatched audience. Above thirty percent usually means the trial is too short, too gated, or scoped to a self-selecting high-intent segment.
Opt-out trials require a card at signup and auto-charge at the end unless the user cancels. They produce fewer signups but higher conversion. Opt-in trials require no card and ask for payment only at the end. They produce more signups but lower conversion. The choice shapes the entire funnel.
Trial length should match time to value, not calendar convenience. Seven days works for simple tools with instant value. Fourteen is the common default. Thirty fits products with onboarding steps. Sixty is reserved for enterprise evaluations. Longer trials rarely convert better and often convert worse.
In a product-led motion the trial is where signup becomes a real evaluation. Signup proves interest. Activation inside the trial proves fit. Conversion at the end proves willingness to pay. Every product-led growth playbook is really a trial playbook with a signup funnel on the front and a billing event on the back.
The length of the trial is the single most argued-about parameter on any pricing page. There is no universal right answer, but there is a right answer for a given product shape, time to value, and buying cycle. The common lengths exist because each one maps to a real pattern of software evaluation.
A one-week trial fits products where a user hits value inside the first session: utilities, converters, generators, simple editors. If a prospect cannot form an opinion in a week, the trial is probably the wrong mechanic and the product should be bought on a demo instead. Short trials filter aggressively.
Two weeks is the industry default for horizontal B2B SaaS. It gives enough time to invite a teammate, run a real workflow, and generate output worth comparing against alternatives. The window is short enough to maintain urgency and long enough to survive a weekend of distraction.
A month-long trial fits products that need setup: data imports, integrations, workflow configuration, team rollout. The clock still exists but it allows for the week where IT finally gets around to the connector. Common for mid-market software and anything that touches another system of record.
Two-month trials are reserved for enterprise sales cycles with procurement, security review, and multiple stakeholders. Nobody signs up for a sixty-day trial on a credit card. These are negotiated inside a sales process and often framed as a paid pilot rather than a trial on the pricing page.
The reflex is to extend the trial to give users more time. The data rarely supports it. Users who do not activate in the first forty-eight hours of a fourteen-day trial almost never activate on day thirteen. Extensions mostly delay the inevitable churn and push revenue later without producing more of it.
The best trial length is the one that comfortably exceeds the median time to first value for the activated cohort. Measure that number, set the trial to roughly double it, and resist the urge to add weeks because a slow user asked. Trial length is a product decision disguised as a marketing decision.
The second-largest variable on a trial is whether the user has to enter a credit card at signup. Opt-out trials auto-charge at the end. Opt-in trials ask for payment at the end. The choice reshapes the funnel from signups to activation to conversion to refund rates. Neither is wrong, but each produces a different business.
The user signs up with just an email, uses the product for the trial window, and is asked for a credit card at the end if they want to continue. Signup volume is high, activation is uneven, and conversion is lower per signup. It is the right choice when top-of-funnel scale is cheap and the product is self-serve.
The user enters a card at signup and is charged automatically when the trial ends unless they cancel. Signup volume drops, but every signup is a far stronger buying signal, and conversion to paid is dramatically higher. Common in categories where buyers expect to pay for software that works.
Across many studies, requiring a card roughly halves signup volume relative to a no-card trial. If the primary goal is top-of-funnel scale or user research, opt-in wins. If the primary goal is pipeline quality and revenue, opt-out usually wins once the model is counted end to end, not just at signup.
Opt-out trials typically convert at twice to three times the rate of opt-in trials on a per-signup basis. The user who entered a card has already made the economic decision; silence equals yes. Opt-in users must make a fresh decision at the end of the window, and most of them simply never return.
Opt-out trials produce a steady stream of refund requests from users who forgot to cancel. The honest operators refund quickly and reduce the gross number to a net number. Refusing refunds or burying cancel flows produces short-term revenue, long-term chargebacks, and a reputation that follows the brand.
Developer tools, horizontal productivity, and consumer-prosumer apps usually run opt-in because the market expects to try before paying. Vertical B2B, financial tools, and anything bought on expense accounts usually run opt-out because entering a card is a normal part of adopting software at work.
A trial is a short pipeline. Every signup is a lead, every activation event is a scoring input, every conversion is a closed-won, and every expiration without conversion is a closed-lost worth analyzing. The CRM is where the mechanic becomes a repeatable system instead of a mystery funnel that leaks revenue in silence.
Trial signups land in the CRM with firmographic enrichment, source attribution, utm context, and the signup event logged. The trial is a lead until it converts, and treating it like a lead means marketing, product, and sales-assist can all operate on the same record without copying data between tools.
In-trial events feed scoring: first import, first invite, first automation, first integration connected. A trial user who has invited a teammate and run a real workflow is a hot lead. The CRM is where those behaviors flip the record from passive signup to active opportunity worth a sales-assist play.
Trial-to-paid conversion is not one number. It is a cohort curve by source, firmographic, trial length, and card requirement. The CRM reports those curves honestly so the team can tell whether paid search converts faster than organic, which segments to lean into, and which to stop spending on.
Not every trial needs a rep. The ones with team scale, stuck activation, or high-intent signals do. Strkr routes those trials to sales-assist with full context on firmographic, usage, invites, and trial day. The outreach is useful rather than generic, and the rest of the trial pool keeps running self-serve.
Day one onboarding, day three invite reminder, day seven feature highlight, day twelve conversion push, day thirteen last call. Lifecycle emails run against the same CRM record, segmented by activation state, so inactive users get a different sequence than active ones and nobody gets the same email twice.
The reporting pack for a trial reads: cost per trial start, cost per activated trial, trial-to-paid rate by cohort, time to convert, revenue per converted cohort, refund rate. If any of those numbers is missing the trial is being flown blind, and the CRM is the system of record that produces all of them.
If the free trial is the GTM mechanic, the CRM is where every signup, activation signal, and conversion decision gets tracked, scored, and acted on. Strkr turns trial starts into a scored pipeline with lifecycle automation and sales-assist routing, so trial-to-paid becomes a number the team can move.
A free trial gives the full paid product for a fixed window, typically seven to sixty days, after which the user must pay or lose access. Freemium gives a permanently free, limited version of the product with no expiration. Trials optimize for urgency and quick conversion. Freemium optimizes for long-tail acquisition and voluntary upgrade over months.
Healthy B2B SaaS trial-to-paid conversion sits between fifteen and twenty-five percent of trial starts. Opt-out trials with a credit card at signup tend to land near the top of that range or higher. Opt-in trials with no card typically sit lower per signup but produce more trial starts, so the net revenue outcome can be similar.
Match trial length to time to value. Seven days for instant-value utilities, fourteen days as the B2B default, thirty days for products with onboarding or integrations, and sixty days reserved for enterprise evaluations and paid pilots. Longer trials rarely improve conversion and often delay the decision without producing more revenue.
Requiring a card roughly halves signup volume but typically doubles or triples conversion per signup. Opt-out trials fit vertical B2B, financial tools, and categories where buyers expect to pay for software at work. Opt-in trials fit developer tools, horizontal productivity, and markets where users expect to try without paying first.
Yes, but sparingly. Extensions make sense when a specific user is close to activation and hit a real blocker like a stalled integration. They do not make sense as a routine save play. Users who did not activate in the first few days almost never activate on day thirteen, and blanket extensions mostly push churn further out without producing conversion.
On an opt-out trial the account auto-charges the stored credit card and continues on the paid plan unless the user cancels. On an opt-in trial the account prompts for payment and is paused, downgraded to a limited plan, or deactivated if no card is added. Clear communication a few days before trial end reduces refund requests and support load.
Not usually. Enterprise buyers evaluate on sales cycles with procurement, security review, and multi-stakeholder scoring. A sixty-day trial can show up as a paid pilot inside that process, but a self-serve credit card trial rarely fits the motion. Enterprise usually runs on demos, pilots, and reference customers rather than open signup trials.
Three stand out: setting the trial length by vibe rather than measured time to value, running a trial on a product that needs a demo to make sense, and treating trial signups as marketing leads rather than active pipeline. The first dilutes conversion, the second produces inactive signups, and the third wastes the single highest-intent audience the product ever sees.
No sales call, no migration consultant, no four-month implementation. Enter your card, get 14 days of the full Pro tier, cancel any time before day 14 with zero charge. Spin up a workspace, import your CSV, and have something useful before lunch.
